Pulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and formed colistin following nebulisation of CMS among patients with ventilator-associated pneumonia-Reference-Cited by-同舟云学术

Pulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and formed colistin following nebulisation of CMS among patients with ventilator-associated pneumonia

Published:2022-06 Issue:6 Volume:59 Page:106588
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Gkoufa Aikaterini,Sou Tomás,Karaiskos Ilias^ORCID,Routsi Christina,Lin Yu-Wei,Psichogiou Mina,Zakynthinos Spyros,Giamarellou Helen,Li Jian,Friberg Lena E.^ORCID

Funder

Swedish Research Council Formas

Vetenskapsrådet

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference44 articles.

1. Ventilator-associated events: prevalence, outcome, and relationship with ventilator-associated pneumonia;Bouadma;Crit Care Med,2015

2. Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study;Koulenti;Eur J Clin Microbiol Infect Dis,2017

3. Resistance trends and treatment options in Gram-negative ventilator-associated pneumonia;Rhodes;Curr Infect Dis Rep,2018

4. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance;Magiorakos;Clin Microbiol Infect,2012

5. Aerosol therapy for pneumonia in the intensive care unit;Luyt;Clin Chest Med,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of intravenous and inhaled polymyxin B treatment in patients with multidrug-resistant gram-negative bacterial pneumonia;International Journal of Antimicrobial Agents;2024-10

2. Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice;Current Opinion in Infectious Diseases;2024-07-30

3. Intrapulmonary and Systemic Pharmacokinetics of Colistin Following Nebulization of Low-Dose Colistimethate Sodium in Patients with Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter baumannii;Antibiotics;2024-03-14

4. Authors response: “Nebulized colistin as the adjunctive treatment for ventilator-associated pneumonia: A systematic review and meta-analysis”;Journal of Critical Care;2024-02

5. Nebulized colistin as the adjunctive treatment for ventilator-associated pneumonia: A systematic review and meta-analysis;Journal of Critical Care;2023-10